Mantle Cell Lymphoma

Swapping bortezomib for vincristine improves PFS in mantle cell lymphoma

Publish date: June 10, 2014

Key clinical point: Substituting bortezomib for vincristine may bring clinical benefit to patients with newly diagnosed mantle cell lymphoma who...

Publish date: May 21, 2014

Publish date: January 10, 2014

Major finding: The response rate was 89% overall and 71% for patients with 17p deletion. Data source: A prospective, phase I dose-escalation study...

Publish date: November 13, 2013

Publish date: June 5, 2013

Publish date: December 13, 2012

Major Finding: In an efficacy cohort of 110 patients with relapsed or refractory mantle cell lymphoma, 22% had a complete response and 46% a...

Publish date: June 29, 2012

Major Finding: Crude prevalences of CNS involvement at diagnosis and overall were 0.9% and 4.1%, respectively, with a median time to an event of...